Integrative "omic" analysis for tamoxifen sensitivity through cell based models

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Weng, Liming ^a   Ziliak, Dana ^a   LaCroix, Bonnie ^a   Geeleher, Paul ^a   Huang, R Stephanie ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DRUG METABOLITE; ENDOXIFEN; MESSENGER RNA; MICRORNA; TAMOXIFEN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

ARTICLE; BIOMICS; BLACK PERSON; BREAST CANCER; CANCER CELL CULTURE; CAUCASIAN; CONTROLLED STUDY; DRUG SENSITIVITY; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE SILENCING; GENOTYPE; HUMAN; HUMAN CELL; PHARMACOGENOMICS; SINGLE NUCLEOTIDE POLYMORPHISM; BREAST NEOPLASMS; FEMALE; GENETICS; HAPLOTYPE MAP; TUMOR CELL LINE;

AFRICAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENOTYPE; HAPMAP PROJECT; HUMANS; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; TAMOXIFEN; TNF RECEPTOR-ASSOCIATED FACTOR 1;

EID: 84899441536     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093420     Document Type: Article

References (27)

1. Møller S, Jensen M-B, Ejlertsen B, Bjerre KD, Larsen M, et al. (2008) The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncol 47: 506-524. (Pubitemid 351878431)
2. Clarke R, Leonessa F, Welch JN, Skaar TC (2001) Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol Rev 53: 25-71. (Pubitemid 32173107)
3. Yang G, Nowsheen S, Aziz K, Georgakilas AG (2013) Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs. Pharmacol Ther 139: 392-404.
4. Newman L (2005) Breast cancer in African-American women. Oncologist 10: 1-14.
5. Jemal A, Ward E, Thun MJ (2007) Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 9: R28.
6. Lin C-Y, Ström A, Vega VB, Kong SL, Yeo AL, et al. (2004) Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells. Genome Biol 5: R66.
7. Filardo EJ, Quinn JA, Frackelton AR, Bland KI (2002) Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-Figure mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16: 70-84. (Pubitemid 34044499)
8. Welsh M, Mangravite L, Medina MW, Tantisira K, Zhang WEI, et al. (2009) Pharmacogenomic Discovery Using Cell-Based Models. 61: 413-429.
9. Huang RS, Johnatty SE, Gamazon ER, Im HK, Ziliak D, et al. (2011) Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients. Clin Cancer Res 17: 5490-5500.
10. Weng L, Ziliak D, Im HK, Gamazon ER, Philips S, et al. (2013) Genome-wide discovery of genetic variants affecting tamoxifen sensitivity and their clinical and functional validation. Ann Oncol: 1-7.
11. Ziliak D, O'Donnell PH, Im HK, Gamazon ER, Chen P, et al. (2011) Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancers. Transl Res 157: 265-272.
12. Al-Nasiry S, Geusens N, Hanssens M, Luyten C, Pijnenborg R (2007) The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum Reprod 22: 1304-1309. (Pubitemid 47062799)
13. Huang RS, Duan S, Shukla SJ, Kistner EO, Clark TA, et al. (2007) Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach. Am J Hum Genet 81: 427-437. (Pubitemid 47330203)
14. Gamazon ER, Ziliak D, Im HK, LaCroix B, Park DS, et al. (2012) Genetic architecture of microRNA expression: implications for the transcriptome and complex traits. Am J Hum Genet 90: 1046-1063.
15. Gamazon ER, Zhang W, Konkashbaev A, Duan S, Kistner EO, et al. (2010) SCAN: SNP and copy number annotation. Bioinformatics 26: 259-262.
16. Heiser LM, Sadanandam A, Kuo W, Benz SC, Goldstein TC, et al. (2012) Subtype and pathway specific responses to anticancer compounds in breast cancer. Proc Natl Acad Sci U S A 109: 2724-2729.
17. Zhao Y, Deng C, Lu W, Xiao J, Ma D, et al. (2011) let-7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor α signaling in breast cancer. Mol Med 17: 1233-1241.
18. Zapata JM, Pawlowski K, Haas E, Ware CF, Godzik a, et al. (2001) A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains. J Biol Chem 276: 24242-24252.
19. Escárcega RO, Fuentes-Alexandro S, García-Carrasco M, Gatica A, Zamora A (2007) The Transcription Factor Nuclear Factor-kappa B and Cancer. Clin Oncol 19: 154-161. (Pubitemid 46172840)
20. Bradley JR, Pober JS (2001) Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20: 6482-6491. (Pubitemid 32977853)
21. Bernassola F, Ciechanover A, Melino G (2010) The ubiquitin proteasome system and its involvement in cell death pathways. Cell Death Differ 17: 1-3.
22. Lee JC, Peter ME (2003) Regulation of apoptosis by ubiquitination. Immunol Rev 193: 39-47. (Pubitemid 36688038)
23. Cao J, Yan Q (2012) Histone ubiquitination and deubiquitination in transcription, DNA damage response, and cancer. Front Oncol 2: 26.
24. Inoue A, Omoto Y, Yamaguchi Y, Kiyama R, Hayashi S-I (2004) Transcription factor EGR3 is involved in the estrogen-signaling pathway in breast cancer cells. J Mol Endocrinol 32: 649-661. (Pubitemid 38877679)
25. Svaren J, Sevetson BR, Apel ED, Zimonjic DB, Popescu NC, et al. (1996) NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol Cell Biol 16: 3545-3553. (Pubitemid 26199873)
26. Mueller MD, Vigne JL, Minchenko A, Lebovic DI, Leitman DC, et al. (2000) Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. Proc Natl Acad Sci U S A 97: 10972-10977.
27. Gamazon ER, Huang RS, Dolan ME, Cox NJ, Im HK (2013) Integrative Genomics: Quantifying Significance of Phenotype-Genotype Relationships from Multiple Sources of High-Throughput Data. Front Genet 3: 1-7.